AbbVie Bid for Biotech Could Expand with Experimental Drug
AbbVie is exploring a cash purchase of about $10.9 billion for a biotech developing an experimental eczema drug, a mo...
Wide Market Index Fund Retirement offers broad exposure to the market with low costs, making it a solid choice for long-term retirement investing and diversification.
28,190 articlesAbbVie is exploring a cash purchase of about $10.9 billion for a biotech developing an experimental eczema drug, a mo...
Micron Technology has surged in 2026, adding roughly a trillion dollars to its market value. But two wild cards—memor...
The Massachusetts Supreme Judicial Court unanimously blocked a statewide rent stabilization petition from the 2026 ba...
Three legacy tech giants are pushing new strategies in 2026 as investors weigh durable enterprise moats against consu...
Signals indicate a cooling phase for stablecoins even as payment giants build out infrastructure. Google Trends shows...
As humanoid robots scale from labs to factories, two equipment makers rise as the hidden winners in the trillion-doll...
AMD and Marvell released quarterly results centered on AI infrastructure, highlighting different strategic bets in da...
A caller on a popular financial show maxed out cards flipping Pokemon. Dave Ramsey’s blunt take highlights the brutal...
XRP has climbed over 9% in the past week and now trades near $1.15 after a brief dip to $1.01. Analysts say the token...
June was rough for tech behemoths, with one member sliding about 12%. This article explains why patient investors may...
VantageScore unveils a new 5.0 model designed to improve credit risk assessment across Equifax, Experian and TransUni...
Jim Cramer argues that Google could win the AI war by leveraging Apple’s massive device base, a move that could redef...